Attrition From Heart Transplant Waiting List for Patients on Ventricular Assist Devices Is Not Affected by Desensitization Strategies

Transplantation Proceedings

Volumn 39, Issue 5, 2007, Pages 1571-1572

  Gonzalez Stawinski, G V ^a   Cook, D J ^a   Smedira, N G ^a   Navia, J L ^a   Taylor, D O ^a   Yamani, M H ^a   Hoercher, K ^a   Starling, R C ^a   Banbury, M K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DACLIZUMAB; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; THYMOCYTE ANTIBODY; WARFARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASSISTED CIRCULATION; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DESENSITIZATION; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HOSPITAL PHARMACY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SEPSIS; STROKE; THROMBOSIS;

ADOLESCENT; ADULT; AGED; FEMALE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; PLASMAPHERESIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WAITING LISTS;

EID: 34250219901     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.03.016     Document Type: Article

References (6)

1. Itescu S., and John R. Interactions between the recipient immune system and the left ventricular assist device surface: immunological and clinical implications. Ann Thorac Surg 75 6 suppl (2003) S58
2. Itescu S., Schuster M., Burke E., et al. Immunobiologic consequences of assist devices. Cardiol Clin 21 (2003) 119
3. Pagani F.D., Dyke D.B., Wright S., et al. Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival. J Heart Lung Transplant 20 (2001) 646
4. Gonzalez-Stawinski G.V., Cook D.J., Chang A.S., et al. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival. J Heart Lung Transplant 25 (2006) 613
5. John R., Lietz K., Burke E., et al. Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. Circulation 100 19 suppl (1999) II229
6. Bustami R.T., Ojo A.O., Wolfe R.A., et al. Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant 4 (2004) 87